These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15764300)

  • 1. Polymorphisms in GSTT1 and p53 and urinary transitional cell carcinoma in south-western Taiwan: a preliminary study.
    Chen YC; Xu L; Guo YL; Su HJ; Smith TJ; Ryan LM; Lee MS; Christiani DC
    Biomarkers; 2004; 9(4-5):386-94. PubMed ID: 15764300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.
    Hsu LI; Chiu AW; Huan SK; Chen CL; Wang YH; Hsieh FI; Chou WL; Wang LH; Chen CJ
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):144-55. PubMed ID: 18199464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
    Djukic T; Simic T; Radic T; Matic M; Pljesa-Ercegovac M; Suvakov S; Coric V; Pekmezovic T; Novakovic I; Dragicevic D; Savic-Radojevic A
    Int Urol Nephrol; 2015 Apr; 47(4):625-30. PubMed ID: 25716313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism in p53 codon 72 and skin cancer in southwestern Taiwan.
    Chen YC; Xu L; Guo YL; Su HJ; Hsueh YM; Smith TJ; Ryan LM; Lee MS; Chaor SC; Lee JY; Christiani DC
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 Jan; 38(1):201-11. PubMed ID: 12635827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
    Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
    Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells.
    Ueda M; Hung YC; Terai Y; Kanda K; Takehara M; Yamashita H; Yamaguchi H; Akise D; Yasuda M; Nishiyama K; Ueki M
    Hum Cell; 2003 Dec; 16(4):241-51. PubMed ID: 15147044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer.
    Abdel-Rahman SZ; Anwar WA; Abdel-Aal WE; Mostafa HM; Au WW
    Cancer Detect Prev; 1998; 22(2):129-38. PubMed ID: 9544433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
    Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
    Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
    Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
    Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.
    Srivastava DS; Kumar A; Mittal B; Mittal RD
    Arch Toxicol; 2004 Aug; 78(8):430-4. PubMed ID: 15057507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
    Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer.
    Kang HW; Tchey DU; Yan C; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Kim IY; Kim WJ
    Urol Oncol; 2014 May; 32(4):458-65. PubMed ID: 24411789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
    Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
    Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
    Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan.
    Shibata A; Ohneseit PF; Tsai YC; Spruck CH; Nichols PW; Chiang HS; Lai MK; Jones PA
    Carcinogenesis; 1994 Jun; 15(6):1085-7. PubMed ID: 8020137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.